abstract |
Disclosed are novel A 2B adenosine receptor antagonists having the structure of Formula I or Formula II: n n nThe compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis. |